Literature DB >> 22817818

Oculopharyngeal muscular dystrophy --an under-diagnosed disease in China? Report a China-born Chinese with PABPN1 mutation and epidemiology review of the literature.

Yu-Yi Chien1.   

Abstract

BACKGROUND/
PURPOSE: Most reports about oculopharyngeal muscular dystrophy (OPMD) have been contributed by occidental countries, and most of the victims of this disease are racially white. In contrast, this disorder is rarely seen in Asians and has only one African report. Consequently, OPMD has been regarded as a disease of the Western world. The purpose of this paper is to challenge the accuracy of this concept.
METHODS: In a Chinese immigrant family, 3 patients manifesting signs related to OPMD were examined. Electromyography, nerve conduction studies, muscle biopsy and genetic analysis were performed on the proband. All the 322 papers about OPMD were reviewed and their country of origin was labeled to perceive the approximate prevalence of OPMD. Countries were categorized into groups according to the continents to which they belonged.
RESULTS: The proband's muscle histopathology showed small angulated fiber with rimmed vacuoles, ultrastructural pathology exposed filamentous intranuclear inclusions, and genetic analysis of the polyadenylate binding protein nuclear 1(PABPN1) gene revealed 13 GCG trinucleotide repeats in one allele (GCG)13 while being normal in the other. The survey of the country of origin of OPMD reports showed that 80% of these papers were contributed by occidental countries and that the number of publications of OPMD among countries of Americas and Asia were unequal, when compared to those of European countries, which were fairly proportioned. An epidemiologic review of the literature is presented and the prevalence of OPMD is discussed.
CONCLUSION: This is a China-born Chinese patient with both morphologically and genetically proven of OPMD. The very low OPMD report rate in developing countries of East Asia is due to the unfamiliarity of medical workers to OPMD and the unavailability of medical supplies to confirm the diagnosis. In addition, the present and previous reports provide clear evidence that OPMD in these areas is underdiagnosed.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817818     DOI: 10.1016/j.jfma.2011.06.017

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

Review 1.  Duchenne muscular dystrophy: current cell therapies.

Authors:  Dorota Sienkiewicz; Wojciech Kulak; Bożena Okurowska-Zawada; Grażyna Paszko-Patej; Katarzyna Kawnik
Journal:  Ther Adv Neurol Disord       Date:  2015-07       Impact factor: 6.570

2.  Oculopharyngeal muscular dystrophy as a rare cause of dysphagia.

Authors:  Sarah Werling; Bertold Schrank; Alexander J Eckardt; Anja Hauburger; Marcus Deschauer; Michaela Müller
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

3.  PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling.

Authors:  Pascale Richard; Capucine Trollet; Teresa Gidaro; Laurence Demay; Guy Brochier; Edoardo Malfatti; Fernando Ms Tom; Michel Fardeau; Pascal Lafor; Norma Romero; Marie-Laure Martin-N; Guilhem Sol; Xavier Ferrer-Monasterio; Jean Lacau Saint-Guily; Bruno Eymard
Journal:  J Neuromuscul Dis       Date:  2015-06-04

4.  Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools.

Authors:  Rick H de Leeuw; Dominique Garnier; Rosemarie M J M Kroon; Corinne G C Horlings; Emile de Meijer; Henk Buermans; Baziel G M van Engelen; Peter de Knijff; Vered Raz
Journal:  Eur J Hum Genet       Date:  2018-11-19       Impact factor: 4.246

5.  Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy.

Authors:  Vered Raz; Rosemarie H M J M Kroon; Hailiang Mei; Muhammad Riaz; Henk Buermans; Saskia Lassche; Corinne Horlings; Bert De Swart; Johanna Kalf; Pradeep Harish; John Vissing; Szymon Kielbasa; Baziel G M van Engelen
Journal:  Int J Mol Sci       Date:  2020-08-22       Impact factor: 5.923

Review 6.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

7.  Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy.

Authors:  Rosemarie H M J M Kroon; Johanna G Kalf; Bert J M de Swart; Barbara M van der Sluijs; Jeffrey C Glennon; Vered Raz; Baziel G van Engelen; Corinne G C Horlings
Journal:  Neurology       Date:  2021-08-11       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.